Multiple Myeloma

March is Multiple Myeloma Awarness Month

Myeloma is the second most common blood cancer. Over 230,000 people worldwide are living with myeloma, with 114,250 news myeloma cases diagnosed each year.
Invivoscribe supports clinicians, researchers & laboratories improving the lives of patients around the world.


Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us